Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Trelagliptin Succinate is a long-acting DPP-4 inhibitor used for type 2 diabetes management. The core synthesis involves succinic acid complexation to enhance stability. Molecular Formula: C21H26F3N5O4. CAS No.: 1098757-46-6.
Application
- Pharmaceutical Manufacturing: Active Pharmaceutical Ingredient (API) production for oral antidiabetic tablets.
- Research & Development: Clinical trial supply for metabolic disease studies and pharmacokinetic profiling.
- Formulation: Raw material sourcing for fixed-dose combination therapies with metformin.
Precautions
Strictly avoid use in patients with severe renal impairment or history of pancreatitis. Store under controlled room temperature in moisture-proof, light-resistant containers. Handle with appropriate PPE to prevent inhalation or skin contact during bulk processing.